|
 
Antisense Therapeutics Limited (ASX code: ANP) is an Australian publicly traded pharmaceutical drug discovery and development company whose mission is to create, develop and commercialise novel antisense therapeutics.
Please click on the following link to access the webcast of the presentation at the Rodman & Renshaw Global Investment Conference (November 12th @ 12.25 to 12.50pm New York time).
This presentation will be available for 90 days.
http://www.wsw.com/webcast/rrshq14/anp.ax
|
